Breaking News
October 16, 2018 - Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
October 16, 2018 - Study reveals early warning signs of heart problems in patients with newly diagnosed lupus
October 16, 2018 - Connecting the dots of Alzheimer’s disease
October 16, 2018 - New publication offers evidence-based content for global breast imaging medical community
October 16, 2018 - ‘EinsteinVision’ that improves hand-eye coordination of surgeons introduced at Harefield Hospital
October 16, 2018 - WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine
October 16, 2018 - Ketamine can be considered as alternative to opioids for short-term pain control in ED
October 16, 2018 - Endurance exercise training beneficially alters gut microbiota composition
October 15, 2018 - FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
October 15, 2018 - Birthing Options for Full-Term Pregnancy
October 15, 2018 - Stressed, toxic, zombie cells seen for first time in Alzheimer’s
October 15, 2018 - Concussion researchers study head motion in high school football hits | News Center
October 15, 2018 - Neuropsychiatric symptoms related to earliest stages of Alzheimer’s brain pathology
October 15, 2018 - Neck collar device may help protect the brain of female high school soccer players
October 15, 2018 - Research reveals how the inner ear processes speech
October 15, 2018 - Many parents still skeptical about safety and effectiveness of flu shot, survey finds
October 15, 2018 - Payer Policies May Discourage Non-Pharma Tx for Low Back Pain
October 15, 2018 - Exercise may delay cognitive decline in people with rare Alzheimer’s disease
October 15, 2018 - Researchers modify CRISPR to reorganize genome | News Center
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Study highlights need for increased support for alcohol-related liver disease patients
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Schiller Easy Pulse Saves Lives
October 15, 2018 - The latest ECG device from Schiller
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
October 15, 2018 - Engineering teratoma-derived fibroblasts to enhance osteogenesis
October 15, 2018 - Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism
October 15, 2018 - JCU study firms up association between diet and depression
October 15, 2018 - Researchers to study the use of CRISPR on human liver on-a-chip platform
October 15, 2018 - Sub-concussive impacts not associated with decline in neurocognitive function
October 15, 2018 - Researchers find potential treatment to halt premature labor and birth
October 15, 2018 - As U.S. suicides rates rise, Hispanics show relative immunity
October 15, 2018 - FDA Issues a Complete Response Letter to Acacia Pharma for Barhemsys
October 15, 2018 - Photoactive bacteria bait may help in fight against MRSA infections
October 15, 2018 - Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children
October 15, 2018 - First-of-its-kind study to test a personalized vaccine in cancer patient
October 15, 2018 - Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia
October 15, 2018 - Half of parents say young children are afraid of doctor’s visits
October 15, 2018 - Study shows how fingerprint-based drug screening works on the living and deceased
October 15, 2018 - Study reveals potential to monitor progression of Alzheimer’s disease by measuring brain antioxidant levels
October 15, 2018 - FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
October 15, 2018 - Promising new therapeutic approach against Ebola virus identified
October 15, 2018 - Study unravels how cancer stem cells use normal genes in abnormal ways
October 15, 2018 - Healthcare systems fail to deliver at affordable prices finds report
October 15, 2018 - Intensive BP Therapy in Diabetes May Lower Risk for CV Events
October 15, 2018 - Muscle relaxants increase risk of respiratory complications
October 15, 2018 - Female birds become more promiscuous after hatchings fail in the first breeding attempt
October 15, 2018 - Humans occupied Madagascar thousands of years later than previously thought
October 15, 2018 - Is Kidney Dialysis Always Needed When Septic Shock Strikes?
October 15, 2018 - Study shows invasive lung cancer surgery can lead to long-term opioid use
October 15, 2018 - Sugar, a “sweet” tool to understand brain injuries
October 14, 2018 - King’s commemorates activities and research on World Arthritis Day
October 14, 2018 - Humana and VFW NY team up on Stop 22 initiative to increase awareness of veterans committing suicide
October 14, 2018 - Water fluoridation contributes to urinary fluoride levels in pregnant women in Canada
October 14, 2018 - Study of children in Romanian orphanages tells cautionary tale about family separation
October 14, 2018 - Previous Endologix AFX Safety Notice classified by FDA as Class I recall
October 14, 2018 - Legal scholars sound alarm on academies’ report about returning research results to participants
October 14, 2018 - UNIST selects six extraordinary scholars to be induced as ‘Rising-star Distinguished Professor’
October 14, 2018 - Scientists find new way to help asthmatics breathe more easily
October 14, 2018 - New ‘gag rule’ may adversely impact health care of pregnant women
October 14, 2018 - Rosacea – Genetics Home Reference
October 14, 2018 - When the fighting crosses the line
October 14, 2018 - New findings could benefit patients with triple-negative breast cancer
Researchers question exclusion of people with prior cancer history from clinical trials

Researchers question exclusion of people with prior cancer history from clinical trials

image_pdfDownload PDFimage_print

A quarter of newly diagnosed cancer patients 65 or older are survivors who had a prior cancer – often preventing them from participating in clinical trials, researchers from UT Southwestern’s Simmons Cancer Center have found.

The UT Southwestern scientists found that 11 percent of individuals ages 20-64 had a history of a prior cancer, and 25 percent of individuals 65 or older had a history of a prior cancer.

As the number of cancer survivors grows, more individuals are being excluded from cancer clinical trials that could benefit them when diagnosed with a second cancer.

“It is an equity issue,” said senior author Dr. Sandi Pruitt, Assistant Professor of Clinical Sciences at UT Southwestern Medical Center. “There are a lot of cancer survivors who are frustrated that they cannot participate in trials that might prolong their lives.”

Among patients 65 and older, individuals with newly diagnosed melanoma, blood cancers, bone and joint cancers, and bladder cancers were most likely to have had prior cancers.

As of January 2016, there were more than 15.5 million cancer survivors in the U.S., representing nearly 5 percent of the population, and that number is expected to grow to 20.3 million by 2026, according to the National Cancer Institute.

“As the cancer survivor population continues to grow, understanding the nature and impact of a prior cancer is crucial to trial recruitment as well as to generalization of results,” said first author Dr. Caitlin Murphy, Assistant Professor of Clinical Sciences at UT Southwestern.

The study, which appears in JAMA Oncology, is the first of this magnitude to examine prior cancer history across many cancer types.

“Trials that come out with information about how to improve cancer treatments may not be representative of this large group of people. It is possible that, for biological reasons, prior cancer survivors may respond differently to some anti-cancer treatments. Thus, providing information about the efficacy of treatments without including these people is a disservice to a large sub-population,” said Dr. Pruitt, a member of the Simmons Cancer Center.

Using an extensive National Cancer Institute data set called Surveillance, Epidemiology and End Results (SEER), the researchers looked at patients with 28 types of cancer diagnosed between the years 2009 and 2013. SEER data has been collected from cancer registries since 1973, so the researchers were able to look for prior cancers across four decades in 740,000 patients who were newly diagnosed with cancers.

This study builds on prior work on lung cancer done by Dr. Pruitt and Dr. David Gerber, Associate Professor of Internal Medicine and Clinical Sciences and a co-author of the current study. “Drs. Pruitt and Gerber have done a lot of work on lung cancer, looking at the impact of prior cancer history on mortality, and they found that there is no difference in overall survival rate. Their findings call into question why people with a prior history of cancer are excluded from new clinical trials,” said Dr. Murphy, a member of the Simmons Cancer Center.

“Previously, we excluded a substantial proportion of potential subjects from lung cancer clinical trials due to prior cancer. The resulting impact on study enrollment was sobering,” said Dr. Gerber, Co-Director of the Lung Disease Oriented Team and Associate Director for Clinical Research in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern. “Our earlier studies showed that most of these prior cancers were early-stage, relatively indolent types, and did not adversely impact clinical outcomes. As a result of our work, many recent lung cancer trials, including those sponsored by the National Cancer Institute, no longer routinely exclude patients with prior cancers.”

Future work by the researchers will focus on individuals with six cancer types – breast cancer, colorectal cancer, pancreatic cancer, non-Hodgkin lymphoma, liver cancer, and kidney cancer – looking at whether patients with a prior history of other cancers are more or less likely to die from their current cancer than individuals with no prior cancer history.

Source:

http://www.utsouthwestern.edu/newsroom/articles/year-2017/cancer-trial-exclusions.html

Tagged with:

About author

Related Articles